Funding · Company
Venatorx Pharmaceuticals, Inc.
Malvern, PABiotech & Pharma
Venatorx Pharmaceuticals, Inc. of Malvern, PA has disclosed $94M across 3 Form D offerings filed with the SEC between Apr 4, 2022 and Jul 13, 2023.
$94M
Total disclosed
3
Form D offerings
This CIK has filed under more than one name: Venatorx Pharmaceuticals, Inc., VenatoRx Pharmaceuticals, Inc.. We use the most recent.
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$35M
Form D · Jul 13, 2023 ↗
Q3 2023
· 1 amendment, first filed Feb 27, 2023
· target $48M
$25M
Form D · Dec 22, 2022 ↗
Q4 2022
· 1 amendment, first filed Sep 2, 2022
$34M
Form D · Apr 4, 2022 ↗
Q2 2022
· target $60M
Filing details
HeadquartersMalvern, PAIndustryBiotech & Pharma (Pharmaceuticals)SEC CIK0001590501Offerings on file3
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →